Search hospitals > Michigan > Ann Arbor
University of Michigan
Claim this profileAnn Arbor, Michigan 48109
Global Leader in Fibrosing Colonopathy
Global Leader in Lymphoma
Conducts research for Cancer
Conducts research for Breast Cancer
Conducts research for Post-Implantation Syndrome
1923 reported clinical trials
266 medical researchers
Summary
University of Michigan is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Fibrosing Colonopathy, Lymphoma, Cancer, Breast Cancer, Post-Implantation Syndrome and other specialties. University of Michigan is involved with conducting 1,923 clinical trials across 2,202 conditions. There are 266 research doctors associated with this hospital, such as Rajen Mody, MD, MS, Elie G. Dib, Paul Swiecicki, and Rashmi Chugh, MD.Area of expertise
1Fibrosing Colonopathy
Global LeaderCFTR positive
CFTR
rs3570920 TT positive
2Lymphoma
Global LeaderStage IV
Stage III
ARID1A positive
Top PIs
Rajen Mody, MD, MSC S Mott Children's Hospital8 years of reported clinical research
Expert in Neuroblastoma
Expert in Cancer
52 reported clinical trials
85 drugs studied
Elie G. DibGenesys Hurley Cancer Institute6 years of reported clinical research
Expert in Parotid Gland Cancer
Studies Multiple Myeloma
38 reported clinical trials
105 drugs studied
Paul SwiecickiUniversity of Michigan Comprehensive Cancer Center5 years of reported clinical research
Studies Parotid Gland Cancer
Studies Melanoma
19 reported clinical trials
29 drugs studied
Rashmi Chugh, MDUniversity of Michigan5 years of reported clinical research
Expert in Soft Tissue Sarcoma
Studies Uterine Leiomyosarcoma
19 reported clinical trials
26 drugs studied
Clinical Trials running at University of Michigan
Multiple Myeloma
Ovarian Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Breast Cancer
Heart Failure
Myelofibrosis
Plasma Cell Neoplasm
Pre-eclampsia
Elranatamab vs Lenalidomide
for Multiple Myeloma
The purpose of this study is to evaluate whether elranatamab monotherapy can provide clinical benefit compared to lenalidomide monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Part 1 and Part 2 of the study, participants in the study will either receive elranatamab (arm A and C) as an injection under the skin at the study clinic or lenalidomide orally once daily at home (arm B). Participation in the study will be approximately five years
Recruiting2 awards Phase 38 criteria
Anitocabtagene Autoleucel
for Multiple Myeloma
The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in participants with RRMM.
Recruiting2 awards Phase 33 criteria
Mezigdomide Combo vs. Pomalidomide Combo
for Multiple Myeloma
This trial is testing two drug combinations to find out which one is better and safer for patients with multiple myeloma that has come back or not responded to previous treatments. The drugs work together to kill cancer cells by stopping their growth, helping the immune system attack them, and making it harder for them to survive.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Michigan?
Where is University of Michigan located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Michigan accept?
What awards or recognition has University of Michigan received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.